{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:01:40Z","timestamp":1793592100076,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009965","name":"American College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.chest.2021.07.056","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T09:09:23Z","timestamp":1627895363000},"page":"2247-2259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":406,"title":["Executive Summary"],"prefix":"10.1016","volume":"160","author":[{"given":"Scott M.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Woller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Baumann Kreuziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Bounameaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Doerschug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert-Jan","family":"Geersing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno V.","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Kearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Knighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Murin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine R.E.","family":"Vintch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Moores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 suppl","key":"10.1016\/j.chest.2021.07.056_bib1","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2021.07.056_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.14-0824","article-title":"Methodologies for the development of CHEST guidelines and expert panel reports [published correction appears in Chest. 2015;148(3):842]","volume":"146","author":"Lewis","year":"2014","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2021.07.056_bib4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"22","key":"10.1016\/j.chest.2021.07.056_bib5","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.chest.2021.07.056_bib6","series-title":"Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing","year":"2020"},{"issue":"4","key":"10.1016\/j.chest.2021.07.056_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jth.13172","article-title":"Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients","volume":"14","author":"van der Hulle","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"10.1016\/j.chest.2021.07.056_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-015-1308-1","article-title":"Guidance for the management of venous thrombosis in unusual sites","volume":"41","author":"Ageno","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"7","key":"10.1016\/j.chest.2021.07.056_bib11","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.chest.2021.07.056_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0268355519835618","article-title":"Catheter-directed thrombolysis vs. anticoagulation for the prevention and treatment of post-thrombotic syndrome in deep vein thrombosis: an updated systematic review and meta-analysis of randomized trials","volume":"34","author":"Mastoris","year":"2019","journal-title":"Phlebology"},{"issue":"11","key":"10.1016\/j.chest.2021.07.056_bib13","first-page":"CD002783","article-title":"Thrombolysis for acute deep vein thrombosis","author":"Watson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11239-015-1318-z","article-title":"Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism","volume":"41","author":"Vedantham","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"15","key":"10.1016\/j.chest.2021.07.056_bib15","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jth.13564","article-title":"Inferior vena cava filters","volume":"15","author":"Duffett","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib17","first-page":"191","article-title":"Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: rationale and design of the HoT-PE trial","volume":"116","author":"Barco","year":"2016","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.chest.2021.07.056_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/M18-1206","article-title":"Increasing safe outpatient management of emergency department patients with pulmonary embolism: a controlled pragmatic trial","volume":"169","author":"Vinson","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11239-015-1317-0","article-title":"Guidance for the treatment of deep vein thrombosis and pulmonary embolism","volume":"41","author":"Streiff","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.chest.2021.07.056_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/rth2.12102","article-title":"Managing thrombosis in cancer patients","volume":"2","author":"Wang","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"11","key":"10.1016\/j.chest.2021.07.056_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.6004\/jnccn.2018.0084","article-title":"NCCN guidelines insights: cancer-associated venous thromboembolic disease, version 2.2018","volume":"16","author":"Streiff","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11239-015-1313-4","article-title":"Guidance for the prevention and treatment of cancer-associated venous thromboembolism","volume":"41","author":"Khorana","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"10","key":"10.1016\/j.chest.2021.07.056_bib23","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.chest.2021.07.056_bib24","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Zuily","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.chest.2021.07.056_bib25","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/0961203320950461","article-title":"16th International Congress on Antiphospholipid Antibodies Task Force report on antiphospholipid syndrome treatment trends","volume":"29","author":"Cohen","year":"2020","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.chest.2021.07.056_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/asheducation-2017.1.223","article-title":"Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosis","volume":"2017","author":"Beyer-Westendorf","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.chest.2021.07.056_bib27","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2352-3026(17)30014-5","article-title":"Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial","volume":"4","author":"Beyer-Westendorf","year":"2017","journal-title":"Lancet Haematol"},{"issue":"19","key":"10.1016\/j.chest.2021.07.056_bib28","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.chest.2021.07.056_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11239-014-1158-2","article-title":"Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results","volume":"40","author":"Amin","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"}],"updated-by":[{"DOI":"10.1016\/j.chest.2022.05.028","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000}}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221015075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221015075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T06:35:26Z","timestamp":1706769326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221015075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0012369221015075"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.07.056","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.chest.2022.05.028","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Executive Summary","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.07.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.07.055","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}